HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].

Abstract
Selective Estrogen Receptor Modulators (SERMs) such as raloxifene are characterized as anti-bone resorptive agent as well as bisphosphonate. Recently, bone mass and quality affect bone strength independently. Oxidative stress induced by hyperhomocysteinemia deteriorates bone quality in terms of collagen enzymatic and non-enzymatic cross-links such as pentosidine (Saito M, Osteoporos Int [REVIEW], 2010). Such deterioration of bone quality also exist in osteoporotic patient with mildly elevated plasma homocysteine (Saito M, Calcif Tissue Int, 2006). Such detrimental cross-link formation in bone was ameliorated by raloxifene treatment (Saito M, Osteoporos Int, 2009, May 30, in press). In contrast. bisphosphonate treatment increases degree of mineralization, collagen maturity, and pentosidine. The treatment had no effect on the total amount of enzymatic cross-link formation (Saito M, Osteoporos Int, 2008). Based on these results, osteoporotic patients with hyperhomocysteinemia had better take raloxifene, while patients with severe low bone mineral density should take bisphosphonate.
AuthorsMitsuru Saito
JournalClinical calcium (Clin Calcium) Vol. 20 Issue 3 Pg. 345-54 (Mar 2010) ISSN: 0917-5857 [Print] Japan
PMID20190364 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Bone Density Conservation Agents
  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride
  • Collagen
Topics
  • Bone Density (drug effects)
  • Bone Density Conservation Agents (pharmacology, therapeutic use)
  • Bone and Bones (metabolism)
  • Calcification, Physiologic (drug effects)
  • Collagen (metabolism)
  • Diphosphonates (pharmacology, therapeutic use)
  • Humans
  • Osteoporosis (classification, drug therapy, etiology, metabolism)
  • Raloxifene Hydrochloride (pharmacology, therapeutic use)
  • Selective Estrogen Receptor Modulators (pharmacology, therapeutic use)
  • Stimulation, Chemical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: